INDUSTRY COMMENTS APPLAUD PART 11 REVISION

Devices & Diagnostics Letter
KEYWORDS comment / FDA / Part 11
A A

Pharmaceutical and medical device companies generally agree that the FDA is doing the right thing to reevaluate its Part 11 rule, but most firms believe that the regulation should not be wiped away completely.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00